세계의 디지털 청진기 시장 : 설계 유형별, 연결성별, 용도별, 최종사용자별, 지역별 - 예측(-2032년)

The global digital stethoscopes market is projected to reach USD 0.71 billion by 2032 from USD 0.49 billion in 2025, at a CAGR of 5.5% during the forecast period.

The global digital stethoscopes market is driven by the growth of telemedicine, remote patient monitoring, and the increasing prevalence of chronic diseases. The integration of artificial intelligence (AI) and the Internet of Things (IoT) is enhancing diagnostic accuracy and connectivity, making these devices more valuable in both clinical and remote settings.

There are significant opportunities in emerging markets, where expanding healthcare infrastructure and increasing investments in digital health support growth. Strategic partnerships and innovations that focus on affordability and AI-driven features further create opportunities for wider adoption and market expansion.

"The wireless digital stethoscopes segment is expected to grow at the highest CAGR during the forecast period."

Wireless digital stethoscopes are becoming an increasingly popular segment of the healthcare market due to the rising demand for flexible and connected solutions. Their ability to enable real-time data sharing and remote diagnostics aligns perfectly with the growing use of telemedicine and home-based care.

Technological advancements-especially in Bluetooth connectivity, cloud integration, and mobile health applications-make these devices more reliable, user-friendly, and compatible with existing digital ecosystems. Additionally, healthcare providers are looking to improve workflow efficiency and patient engagement, and the mobility and convenience of wireless models are driving their adoption.

This growth is further supported by increased investments in digital health infrastructure and a push for scalable, interoperable tools that enhance access to care, particularly in underserved or remote areas.

"The teleconsultation & remote monitoring segment is expected to grow at the highest rate during the forecast period."

The digital stethoscopes market is segmented by application into four categories: cardiology auscultation, pulmonary auscultation, abdominal auscultation, and teleconsultation & remote monitoring. Among these, the teleconsultation & remote monitoring segment is experiencing the highest growth. This increase is driven by a global shift toward virtual healthcare, which has been accelerated by the demand for safe, contactless consultations and effective chronic disease management.

Digital stethoscopes play a vital role in enabling real-time, high-quality auscultation during teleconsultations, thereby enhancing diagnostic accuracy from a distance. Their integration with remote monitoring platforms allows for continuous patient assessments, which reduces the need for hospital visits and facilitates early intervention. As healthcare systems increasingly prioritize home-based care and digital health solutions, this segment continues to expand rapidly, supported by advancements in connectivity, artificial intelligence, and patient-friendly technologies.

"North America accounted for the largest share of the digital stethoscopes market in 2024."

The global market for digital stethoscopes is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is currently the largest regional market for digital stethoscopes, while the Asia Pacific market is expected to experience the highest CAGR during the forecast period. The significant market share in North America can be attributed to the high prevalence of chronic diseases, such as cardiovascular conditions, which creates a larger patient base in need of diagnostic tools like digital stethoscopes. Additionally, the presence of several key market players in the region is likely to further enhance the growth of the digital stethoscopes market in North America.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
• By Designation: C-level Executives (30%), D-level Executives (23%), and Others (47%)
• By Region: North America (35%), Europe (20%), Asia Pacific (25%), Latin America (13%), and the Middle East & Africa (7%)

The major players operating in the digital stethoscopes market are Solventum (US), Eko Health, Inc. (US), Thinklabs (US), HD Medical, Inc. (US), Linktop (China), TaiDoc Technology Corporation (Taiwan), GS Technology (South Korea), AMD Global Telemedicine (US), Guangdong Hanhong Medical Technology Co., Ltd. (China), and Qingdao Meditech Equipment Co., Ltd. (China).

Research Coverage

This report examines the digital stethoscopes market by analyzing various factors, including design type, connectivity, application, and region. It also evaluates elements that influence market growth, such as drivers, restraints, opportunities, and challenges. Additionally, the report provides insights into the competitive landscape, highlighting the leading players in the market. Furthermore, it explores micromarkets to understand their individual growth trends and offers revenue forecasts for different market segments across five major regions, along with the specific countries within those regions.

Reasons to Buy the Report

The report will allow both established companies and smaller entrants to understand the current state of the market, which will help them increase their market share. Firms that purchase the report can implement one or a combination of the strategies mentioned below to enhance their market presence.

This report provides insights on the following pointers:

• Analysis of key drivers [surge in telemedicine and remote patient monitoring and integration of artificial intelligence (Al) and internet of things (loT)], restraints (high cost and affordability issues and resistance from traditional practitioners), opportunities (untapped growth potential in emerging markets and product innovations and strategic partnerships), and challenges (limited technical training and user familiarity and battery life and device reliability issues)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the digital stethoscopes market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the digital stethoscopes market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the digital stethoscopes market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 SEGMENTS CONSIDERED & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources of secondary research
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key objectives of primary research
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Breakdown of primaries
• 2.2 MARKET SIZE ESTIMATION OF DIGITAL STETHOSCOPES
  • 2.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)
  • 2.2.2 COMPANY INVESTOR PRESENTATIONS AND PRIMARY INTERVIEWS
• 2.3 TOP-DOWN APPROACH
• 2.4 MARKET GROWTH RATE PROJECTION
• 2.5 DATA TRIANGULATION
  • 2.5.1 STUDY ASSUMPTIONS
  • 2.5.2 RESEARCH LIMITATIONS
  • 2.5.3 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 DIGITAL STETHOSCOPES MARKET OVERVIEW
• 4.2 ASIA PACIFIC: DIGITAL STETHOSCOPES MARKET, BY APPLICATION AND COUNTRY (2024)
• 4.3 DIGITAL STETHOSCOPES MARKET: REGIONAL GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 MARKET DYNAMICS
  • 5.1.1 DRIVERS
    • 5.1.1.1 Surge in telemedicine and remote patient monitoring
    • 5.1.1.2 Growing incidence of cardiovascular and respiratory diseases
    • 5.1.1.3 Integration of artificial intelligence and Internet of Things
  • 5.1.2 RESTRAINTS
    • 5.1.2.1 High cost and affordability issues
    • 5.1.2.2 Resistance from traditional practitioners
  • 5.1.3 OPPORTUNITIES
    • 5.1.3.1 Untapped growth potential in emerging markets
    • 5.1.3.2 Product innovation and strategic partnerships
  • 5.1.4 CHALLENGES
    • 5.1.4.1 Limited technical training and user familiarity
    • 5.1.4.2 Battery life and device reliability issues
• 5.2 INDUSTRY TRENDS
  • 5.2.1 AI-POWERED DIGITAL STETHOSCOPES AND TELEHEALTH
  • 5.2.2 WEARABLE HEALTH MONITORING
• 5.3 TECHNOLOGY ANALYSIS
  • 5.3.1 KEY TECHNOLOGIES
    • 5.3.1.1 AI-powered auscultation
    • 5.3.1.2 Noise cancellation and sound amplification
  • 5.3.2 COMPLEMENTARY TECHNOLOGIES
    • 5.3.2.1 Integration with mobile applications
    • 5.3.2.2 Multi-functionality and sensor integration
  • 5.3.3 ADJACENT TECHNOLOGIES
    • 5.3.3.1 Wearable health monitors
• 5.4 PORTER'S FIVE FORCES ANALYSIS
  • 5.4.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4.2 BARGAINING POWER OF SUPPLIERS
  • 5.4.3 BARGAINING POWER OF BUYERS
  • 5.4.4 THREAT OF SUBSTITUTES
  • 5.4.5 THREAT OF NEW ENTRANTS
• 5.5 REGULATORY LANDSCAPE
  • 5.5.1 REGULATORY FRAMEWORK
    • 5.5.1.1 North America
    • 5.5.1.2 Europe
    • 5.5.1.3 Asia Pacific
    • 5.5.1.4 Latin America
    • 5.5.1.5 Middle East & Africa
  • 5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.6 PATENT ANALYSIS
  • 5.6.1 JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.7 TRADE ANALYSIS
  • 5.7.1 IMPORT DATA FOR HS CODE 901890
  • 5.7.2 EXPORT DATA FOR HS CODE 901890
• 5.8 REIMBURSEMENT SCENARIO
• 5.9 KEY CONFERENCES & EVENTS (2025-2026)
• 5.10 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.10.2 BUYING CRITERIA
• 5.11 UNMET NEEDS/END USER EXPECTATIONS IN DIGITAL STETHOSCOPES MARKET
• 5.12 SUPPLY CHAIN ANALYSIS
• 5.13 VALUE CHAIN ANALYSIS
• 5.14 IMPACT OF GEN AI ON DIGITAL STETHOSCOPES MARKET
• 5.15 PRICING ANALYSIS
• 5.16 MARKET ECOSYSTEM
  • 5.16.1 ROLE IN ECOSYSTEM
• 5.17 CASE STUDY ANALYSIS
• 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.19 INVESTMENT & FUNDING SCENARIO
• 5.20 IMPACT OF 2025 US TARIFF
  • 5.20.1 INTRODUCTION
  • 5.20.2 KEY TARIFF RATES
  • 5.20.3 PRICE IMPACT ANALYSIS
  • 5.20.4 IMPACT ON COUNTRY/REGION
  • 5.20.5 IMPACT ON END-USE SEGMENTS

6 DIGITAL STETHOSCOPES MARKET, BY APPLICATION

• 6.1 INTRODUCTION
• 6.2 CARDIOLOGY AUSCULTATION
  • 6.2.1 AI-ENHANCED DIAGNOSTICS DRIVE SEGMENT GROWTH
• 6.3 PULMONARY AUSCULTATION
  • 6.3.1 ADVANCEMENTS IN LUNG SOUND ANALYSIS IMPROVE PULMONARY DIAGNOSTICS
• 6.4 ABDOMINAL AUSCULTATION
  • 6.4.1 ENHANCES GASTROINTESTINAL SOUND DETECTION TO DRIVE SEGMENT
• 6.5 TELECONSULTATION & REMOTE MONITORING
  • 6.5.1 INTEGRATION OF TELEHEALTH IN HEALTHCARE TO BOOST SEGMENT

7 DIGITAL STETHOSCOPES MARKET, BY CONNECTIVITY

• 7.1 INTRODUCTION
• 7.2 WIRELESS DIGITAL STETHOSCOPES
  • 7.2.1 EXPANDING REMOTE CARE AND ADVANCED TECHNOLOGY FUEL SEGMENT GROWTH
• 7.3 WIRED DIGITAL STETHOSCOPES
  • 7.3.1 CLINICAL DEPENDABILITY AND RISING RESPIRATORY BURDEN DRIVE ADOPTION

8 DIGITAL STETHOSCOPES MARKET, BY DESIGN TYPE

• 8.1 INTRODUCTION
• 8.2 TUBE-BASED DIGITAL STETHOSCOPES
  • 8.2.1 GROWING TELEHEALTH ECOSYSTEM AND AI INTEGRATION TO BOOST ADOPTION
• 8.3 TUBELESS DIGITAL STETHOSCOPES
  • 8.3.1 ADVANCE CARDIAC AND RESPIRATORY MONITORING IN REMOTE CARE TO DRIVE SEGMENT

9 DIGITAL STETHOSCOPES MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS & CLINICS
  • 9.2.1 AI-POWERED DIAGNOSTICS IN HOSPITAL SETTINGS DRIVE ADOPTION
• 9.3 PRIMARY CARE CENTERS
  • 9.3.1 POINT-OF-CARE DIAGNOSIS IN PRIMARY SETTINGS ACCELERATES UPTAKE
• 9.4 AMBULATORY CARE CENTERS
  • 9.4.1 DEMAND FOR MULTIFUNCTIONAL DIAGNOSTICS WITH SMART STETHOSCOPES TO FUEL SEGMENT
• 9.5 URGENT CARE CENTERS
  • 9.5.1 QUICKER PATIENT CHECKS AND HIGH-QUALITY CARE WITH AI-BASED STETHOSCOPES TO FUEL SEGMENT
• 9.6 HOME CARE SETTINGS
  • 9.6.1 REMOTE PATIENT MONITORING IN HOMES BOOSTS DEMAND
• 9.7 OTHER END USERS

10 DIGITAL STETHOSCOPES MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 Dominant North American digital stethoscopes market during forecast period
  • 10.2.3 CANADA
    • 10.2.3.1 Telehealth and rural healthcare focus to propel market growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Market growth accelerated with AI integration into digital stethoscopes
  • 10.3.3 UK
    • 10.3.3.1 Government digital health initiatives to drive market growth
  • 10.3.4 FRANCE
    • 10.3.4.1 AI adoption and telehealth bolster growth of market
  • 10.3.5 ITALY
    • 10.3.5.1 Strategic Integration of AI in public healthcare to drive market growth
  • 10.3.6 SPAIN
    • 10.3.6.1 Growing aging population and remote care to augment market growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 Increasing aging population and digital health integration to support market growth
  • 10.4.3 JAPAN
    • 10.4.3.1 Technology-driven healthcare and increasing aging population to drive market
  • 10.4.4 INDIA
    • 10.4.4.1 Government initiatives and innovative digital solutions to boost market
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Increased geriatric patient pool and government support to fuel growth
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Rising geriatric population to drive market
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Expanding healthcare access in Brazil fuels market growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Growing chronic disease burden and digital health adoption to drive market
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Saudi Arabia
      • 10.6.2.1.1 Surge in prevalence of CVDs to boost adoption
    • 10.6.2.2 UAE
      • 10.6.2.2.1 Government initiatives in healthcare infrastructure to drive market
    • 10.6.2.3 Other GCC Countries
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL STETHOSCOPES MARKET
• 11.3 REVENUE ANALYSIS, 2020-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.4.1 RANKING OF KEY PLAYERS
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Design type footprint
    • 11.5.5.4 Connectivity footprint
    • 11.5.5.5 Application footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 11.6.5.1 Detailed list of key startup/SME players
    • 11.6.5.2 Competitive benchmarking of key startups/SME players
• 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.7.1 FINANCIAL METRICS
  • 11.7.2 COMPANY VALUATION
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES & APPROVALS
  • 11.9.2 DEALS
  • 11.9.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 SOLVENTUM
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Other developments
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Right to win
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 EKO HEALTH, INC.
    • 12.1.2.1 Business overview
    • 12.1.2.2 Recent developments
      • 12.1.2.2.1 Product launches and approvals
      • 12.1.2.2.2 Deals
    • 12.1.2.3 MnM view
      • 12.1.2.3.1 Right to win
      • 12.1.2.3.2 Strategic choices
      • 12.1.2.3.3 Weaknesses & competitive threats
  • 12.1.3 THINKLABS
    • 12.1.3.1 Business overview
    • 12.1.3.2 Recent developments
      • 12.1.3.2.1 Deals
    • 12.1.3.3 MnM view
      • 12.1.3.3.1 Right to win
      • 12.1.3.3.2 Strategic choices
      • 12.1.3.3.3 Weaknesses & competitive threats
  • 12.1.4 TAIDOC TECHNOLOGY CORPORATION
    • 12.1.4.1 Business overview
    • 12.1.4.2 MnM view
      • 12.1.4.2.1 Right to win
      • 12.1.4.2.2 Strategic choices
      • 12.1.4.2.3 Weaknesses & competitive threats
  • 12.1.5 HD MEDICAL, INC.
    • 12.1.5.1 Business overview
    • 12.1.5.2 MnM view
      • 12.1.5.2.1 Right to win
      • 12.1.5.2.2 Strategic choices
      • 12.1.5.2.3 Weaknesses & competitive threats
  • 12.1.6 LINKTOP
    • 12.1.6.1 Business overview
  • 12.1.7 GS TECHNOLOGY
    • 12.1.7.1 Business overview
  • 12.1.8 AMD GLOBAL TELEMEDICINE
    • 12.1.8.1 Business overview
    • 12.1.8.2 Recent developments
      • 12.1.8.2.1 Deals
  • 12.1.9 GUANGDONG HANHONG MEDICAL TECHNOLOGY CO., LTD.
    • 12.1.9.1 Business overview
  • 12.1.10 QINGDAO MEDITECH EQUIPMENT CO., LTD
    • 12.1.10.1 Business overview
• 12.2 OTHER PLAYERS
  • 12.2.1 AYU DEVICES PVT LTD.
  • 12.2.2 VISIONFLEX PTY LIMITED
  • 12.2.3 CARDIONICS INC.
  • 12.2.4 AI HEALTH HIGHWAY INDIA PVT LTD.
  • 12.2.5 M3DICINE PTY LTD.
  • 12.2.6 MEDAICA
  • 12.2.7 TYTOCARE LTD.
  • 12.2.8 IMEDI PLUS
  • 12.2.9 AEVICE HEALTH PTE LTD.
  • 12.2.10 STRADOS LABS
  • 12.2.11 SAINTIANT TECHNOLOGIES
  • 12.2.12 HEROIC-FAITH
  • 12.2.13 SONAVI LABS HQ
  • 12.2.14 GV CONCEPTS, INC.
  • 12.2.15 STETHOME SP. Z O.O.
  • 12.2.16 EKUORE MEDICAL DEVICES

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS